PRPL
Purple Innovation, Inc. NASDAQ Listed Oct 29, 2015$0.41
Mkt Cap $44.4M
52w Low $0.39
2.2% of range
52w High $1.25
50d MA $0.48
200d MA $0.71
P/E (TTM)
-0.7x
EV/EBITDA
—
P/B
—
Debt/Equity
-6.9x
ROE
104.5%
P/FCF
-1.1x
RSI (14)
47.10
ATR (14)
$0.03
Beta
1.84
50d MA
$0.48
200d MA
$0.71
Avg Volume
368.6K
Purple Innovation, Inc. designs and manufactures mattresses, pillows, and cushions. The company also offers bases, foundations, sheets, mattress protectors, bed frames, seat cushions, weighted blankets, and duvets, as well as pet beds. It markets and sells its products through its e-commerce online channels retail brick-and-mortar wholesale partners, and third-party online retailers, as well as through Purple retail showrooms. The company was founded in 2010 and is headquartered in Lehi, Utah.
4100 North Chapel Ridge Road · Lehi, UT 84043 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | BMO | -0.13 | -0.13 | +0.0% | 0.64 | -8.6% | -17.1% | -8.3% | +1.0% | +0.9% | -5.0% | — |
| Mar 31, 2026 | BMO | -0.04 | -0.02 | +50.0% | 0.65 | +2.1% | +2.0% | +2.1% | -3.3% | +1.4% | -3.7% | — |
| Nov 4, 2025 | BMO | -0.09 | -0.08 | +11.1% | 0.80 | +0.4% | +1.3% | -11.0% | -2.6% | +18.5% | -8.1% | — |
| Jul 29, 2025 | BMO | -0.12 | -0.11 | +8.3% | 1.00 | +1.0% | -15.0% | -3.8% | -0.7% | -0.3% | +5.1% | — |
| May 6, 2025 | BMO | -0.14 | -0.11 | +21.4% | 0.66 | +8.8% | +12.1% | +10.2% | -1.3% | -2.4% | +19.0% | — |
| Mar 13, 2025 | BMO | -0.14 | -0.07 | +50.0% | 0.71 | -0.8% | -6.0% | +35.6% | -5.8% | -1.9% | -2.1% | — |
| Nov 4, 2024 | BMO | -0.10 | -0.08 | +20.0% | 0.91 | +0.5% | +3.3% | -12.0% | +3.1% | -4.8% | +2.8% | — |
| Aug 5, 2024 | BMO | -0.11 | -0.13 | -18.2% | 1.25 | -8.0% | -5.6% | -8.5% | -0.9% | -3.7% | +1.0% | — |
| May 7, 2024 | BMO | -0.15 | -0.19 | -26.7% | 1.70 | +1.2% | -1.2% | -8.9% | +2.6% | -1.9% | -5.2% | — |
| Mar 12, 2024 | BMO | -0.19 | -0.15 | +21.1% | 1.96 | +3.6% | +4.1% | -18.6% | -9.6% | +4.0% | -3.2% | — |
| Nov 9, 2023 | BMO | -0.03 | -0.18 | -620.0% | 0.92 | +0.3% | -10.7% | -31.1% | +3.9% | +4.1% | +2.9% | — |
| Aug 9, 2023 | BMO | -0.12 | -0.20 | -66.7% | 3.07 | -0.7% | -11.1% | -13.2% | +3.0% | -4.9% | +1.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | UBS | Maintains | Neutral → Neutral | — | $0.53 | $0.52 | -3.0% | -8.3% | +1.0% | +0.9% | -5.0% | +3.9% |
| Apr 29 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $0.53 | $0.52 | -3.0% | -8.3% | +1.0% | +0.9% | -5.0% | +3.9% |
| Apr 1 | UBS | Maintains | Neutral → Neutral | — | $0.66 | $0.67 | +1.3% | +2.1% | -3.3% | +1.4% | -3.7% | -5.4% |
| Mar 26 | Wedbush | Maintains | Neutral → Neutral | — | $0.79 | $0.80 | +1.3% | -2.9% | +2.1% | -4.0% | +1.1% | -1.4% |
| Sep 4 | Wedbush | Downgrade | Outperform → Neutral | — | $1.11 | $1.10 | -0.9% | -1.8% | -0.9% | -5.6% | -1.0% | -3.0% |
| Aug 6 | Craig-Hallum | Maintains | Hold → Hold | — | $1.18 | $1.20 | +1.7% | -8.5% | -0.9% | -3.7% | +1.0% | +0.0% |
| May 8 | Wedbush | Maintains | Outperform → Outperform | — | $1.68 | $1.53 | -8.9% | -8.9% | +2.6% | -1.9% | -5.2% | +1.4% |
| Mar 21 | Roth MKM | Maintains | Buy → Buy | — | $1.61 | $1.61 | +0.0% | +1.9% | -7.3% | -5.3% | +3.5% | +4.7% |
| Mar 13 | Craig-Hallum | Maintains | Hold → Hold | — | $2.04 | $2.05 | +0.5% | -18.6% | -9.6% | +4.0% | -3.2% | +1.3% |
| Mar 13 | Wedbush | Maintains | Outperform → Outperform | — | $2.04 | $2.05 | +0.5% | -18.6% | -9.6% | +4.0% | -3.2% | +1.3% |
| Mar 13 | Roth MKM | Upgrade | Neutral → Buy | — | $2.04 | $2.05 | +0.5% | -18.6% | -9.6% | +4.0% | -3.2% | +1.3% |
| Mar 7 | Roth MKM | Maintains | Neutral → Neutral | — | $1.85 | $1.92 | +3.8% | +7.6% | -2.0% | +0.5% | +4.1% | -18.6% |
| Jan 24 | Wedbush | Maintains | Outperform → Outperform | — | $0.82 | $0.98 | +19.4% | +25.5% | -2.9% | +5.0% | -1.9% | -4.6% |
| Jan 24 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $0.82 | $0.98 | +19.4% | +25.5% | -2.9% | +5.0% | -1.9% | -4.6% |
| Nov 13 | Oppenheimer | Downgrade | Outperform → Perform | — | $0.56 | $0.58 | +2.9% | +3.9% | +4.1% | +2.9% | -5.4% | +13.0% |
| Nov 10 | Craig-Hallum | Downgrade | Buy → Hold | — | $0.82 | $0.69 | -15.8% | -31.1% | +3.9% | +4.1% | +2.9% | -5.4% |
| Nov 10 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $0.82 | $0.69 | -15.8% | -31.1% | +3.9% | +4.1% | +2.9% | -5.4% |
| Nov 10 | Wedbush | Maintains | Outperform → Outperform | — | $0.82 | $0.69 | -15.8% | -31.1% | +3.9% | +4.1% | +2.9% | -5.4% |
| Aug 25 | Oppenheimer | Maintains | Outperform → Outperform | — | $2.04 | $2.04 | +0.0% | +6.4% | +0.9% | +0.9% | +0.5% | -2.3% |
| Aug 10 | Wedbush | Maintains | Outperform → Outperform | — | $2.73 | $2.40 | -12.1% | -13.2% | +3.0% | -4.9% | +1.3% | +0.0% |
| Apr 14 | Wedbush | Maintains | Outperform → Outperform | — | $2.24 | $2.53 | +12.9% | +13.4% | +4.3% | +7.9% | -2.4% | -3.6% |
| Mar 21 | UBS | Maintains | Neutral → Neutral | — | $2.60 | $2.57 | -1.2% | -1.9% | +8.6% | +4.7% | -7.6% | -6.3% |
| Feb 1 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $5.80 | $5.99 | +3.3% | +6.7% | +2.9% | -3.5% | -5.4% | -2.7% |
| Jan 12 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $5.67 | $5.85 | +3.2% | +4.1% | -2.4% | +0.3% | -0.2% | -4.5% |
| Nov 10 | Craig-Hallum | Upgrade | Hold → Buy | — | $3.41 | $4.05 | +18.8% | +31.1% | +18.1% | +0.8% | +2.3% | -6.2% |
| Sep 20 | Wedbush | Maintains | Outperform → Outperform | — | $3.89 | $3.90 | +0.3% | +1.3% | +3.6% | -4.2% | +2.3% | -2.8% |
| Sep 20 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $3.89 | $3.90 | +0.3% | +1.3% | +3.6% | -4.2% | +2.3% | -2.8% |
| Mar 28 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $6.32 | $6.32 | +0.0% | -5.2% | +3.2% | +4.2% | -9.2% | +0.9% |
| Mar 2 | Roth Capital | Downgrade | Buy → Neutral | — | $5.73 | $5.05 | -11.9% | +16.1% | +14.4% | -0.5% | -13.6% | +6.7% |
| Mar 2 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $5.73 | $5.05 | -11.9% | +16.1% | +14.4% | -0.5% | -13.6% | +6.7% |
| Dec 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $9.80 | $8.80 | -10.2% | -6.6% | +2.2% | +16.6% | +7.8% | +4.3% |
| Dec 14 | Wedbush | Maintains | Outperform → Outperform | — | $9.80 | $8.80 | -10.2% | -6.6% | +2.2% | +16.6% | +7.8% | +4.3% |
| Nov 10 | Raymond James | Downgrade | Outperform → Market Perform | — | $19.20 | $13.76 | -28.3% | -24.5% | -6.6% | -1.5% | +0.4% | +0.0% |
| Nov 10 | Truist | Downgrade | Buy → Hold | — | $19.20 | $13.76 | -28.3% | -24.5% | -6.6% | -1.5% | +0.4% | +0.0% |
| Nov 10 | UBS | Downgrade | Buy → Neutral | — | $19.20 | $13.76 | -28.3% | -24.5% | -6.6% | -1.5% | +0.4% | +0.0% |
| Nov 10 | B. Riley Securities | Downgrade | Buy → Neutral | — | $19.20 | $13.76 | -28.3% | -24.5% | -6.6% | -1.5% | +0.4% | +0.0% |
| Nov 10 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $19.20 | $13.76 | -28.3% | -24.5% | -6.6% | -1.5% | +0.4% | +0.0% |
| Nov 8 | BofA Securities | Downgrade | Buy → Underperform | — | $19.50 | $18.01 | -7.6% | -2.4% | +0.9% | -24.5% | -6.6% | -1.5% |
| Oct 4 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $21.20 | $21.01 | -0.9% | -0.7% | +1.5% | +1.6% | +1.9% | -3.5% |
| Sep 28 | Craig-Hallum | Downgrade | Buy → Hold | — | $23.01 | $22.34 | -2.9% | -3.1% | -1.1% | -4.7% | +0.9% | -0.7% |
| Aug 11 | Roth Capital | Maintains | Buy → Buy | — | $26.57 | $26.65 | +0.3% | +3.8% | -0.9% | -2.2% | -2.9% | -2.6% |
| Jul 1 | Roth Capital | Maintains | Buy → Buy | — | $26.41 | $26.50 | +0.3% | +5.6% | -2.6% | -0.1% | -1.4% | -2.6% |
| Jun 30 | Raymond James | Maintains | Outperform → Outperform | — | $26.79 | $26.57 | -0.8% | -1.4% | +5.6% | -2.6% | -0.1% | -1.4% |
| May 18 | Roth Capital | Maintains | Buy → Buy | — | $32.02 | $32.22 | +0.6% | +0.9% | -4.0% | +0.5% | -6.9% | -0.4% |
| May 18 | Raymond James | Maintains | Outperform → Outperform | — | $32.02 | $32.22 | +0.6% | +0.9% | -4.0% | +0.5% | -6.9% | -0.4% |
| Mar 5 | KeyBanc | Maintains | Overweight → Overweight | — | $24.37 | $25.81 | +5.9% | +27.9% | -4.5% | +4.6% | +5.6% | +2.8% |
| Mar 5 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $24.37 | $25.81 | +5.9% | +27.9% | -4.5% | +4.6% | +5.6% | +2.8% |
| Mar 5 | Raymond James | Maintains | Outperform → Outperform | — | $24.37 | $25.81 | +5.9% | +27.9% | -4.5% | +4.6% | +5.6% | +2.8% |
| Mar 4 | KeyBanc | Maintains | Overweight → Overweight | — | $36.15 | $27.90 | -22.8% | -32.6% | +27.9% | -4.5% | +4.6% | +5.6% |
| Feb 9 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $39.77 | $40.12 | +0.9% | -4.2% | -3.9% | +5.2% | +2.6% | -1.3% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Lucian Robert GerardOff | Chief Financial Officer | Buy | 60,000 | $0.49 | $29K | 60,000 | -0.16% | +5.11% |
8-K
Purple Innovation, Inc. -- 8-K Filing
Jun 10
8-K · 7.01
! Medium
Purple Innovation, Inc. -- 8-K 7.01: Regulation FD Disclosure
Purple Innovation appointed Robert G. Lucian as Chief Financial Officer, a leadership change that may signal shifts in financial strategy and operational direction for the mattress and furniture company.
Apr 28
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
Purple's new debt agreement with Coliseum Capital Partners likely refinances existing obligations, which could reduce financial pressure but may involve dilutive terms or covenants that limit operational flexibility.
Mar 31
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Wasatch Advisors Lp | 5,071,444 | $3M | Reduced | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 2,254,889 | $1M | New | Mar 2026 |
| 3 | Millennium Management | 848,774 | $561K | Reduced | Mar 2026 |
| 4 | Dynamic Advisor Solutions Llc | 752,200 | $519K | — | Dec 2025 |
| 5 | Renaissance Technologies Llc | 677,654 | $448K | Reduced | Mar 2026 |
| 6 | Anson Funds Management Lp | 600,000 | $397K | — | Mar 2026 |
| 7 | Jpmorgan Chase & Co | 328,635 | $213K | Reduced | Mar 2026 |
| 8 | Crumly & Associates Inc. | 292,063 | $193K | Added | Mar 2026 |
| 9 | Stratos Wealth Partners, Ltd. | 273,161 | $181K | — | Mar 2026 |
| 10 | Jane Street Group, Llc | 150,197 | $104K | Added | Dec 2025 |
| 11 | Tudor Investment Corp | 150,649 | $100K | New | Mar 2026 |
| 12 | Divisadero Street Capital Management, Lp | 138,605 | $92K | — | Mar 2026 |
| 13 | Midwest Financial Group Llc | 115,000 | $76K | — | Mar 2026 |
| 14 | B.o.s.s. Retirement Advisors, Llc | 100,000 | $66K | — | Mar 2026 |
| 15 | Northern Trust Corp | 97,227 | $64K | — | Mar 2026 |
| 16 | Citadel Advisors Llc | 64,822 | $43K | Reduced | Mar 2026 |
| 17 | Ubs Group Ag | 57,511 | $38K | Added | Mar 2026 |
| 18 | Acadian Asset Management Llc | 50,018 | $32K | Reduced | Mar 2026 |
| 19 | Simplex Trading, Llc | 46,805 | $31K | Added | Mar 2026 |
| 20 | Woodley Farra Manion Portfolio Management Inc | 30,480 | $20K | — | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 10
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Wasatch Micro Cap Fund | 5,024,165 | $3M | Mar 2026 |
| 2 | Invenomic Fund | 446,314 | $307K | Jan 2026 |
| 3 | Fidelity Extended Market Index Fund | 295,879 | $206K | Feb 2026 |
| 4 | Schwab U.S. Small-Cap ETF | 285,420 | $198K | Feb 2026 |
| 5 | Fidelity Total Market Index Fund | 100,513 | $70K | Feb 2026 |
| 6 | Fidelity Series Total Market Index Fund | 76,384 | $53K | Feb 2026 |
| 7 | Ultra-Small Company Market Fund | 75,000 | $50K | Mar 2026 |
| 8 | Fidelity Nasdaq Composite Index Fund | 31,058 | $22K | Feb 2026 |
| 9 | Guggenheim Active Allocation Fund | 343 | $238 | Feb 2026 |
| 10 | Knights of Columbus U.S. ALL CAP INDEX FUND | 280 | $192 | Jan 2026 |
Valuation
Market Cap
$44.4M
Enterprise Value
$131.4M
P/E (TTM)
-0.71x
Forward P/E
—
PEG Ratio
0.03x
P/B
—
P/S
0.10x
P/FCF
-1.06x
EV/EBITDA
—
Shares Out
108.2M
Financials (TTM)
Revenue
$460.3M
Net Income
-$62.8M
EBITDA
-$7.0M
Free Cash Flow
-$41.9M
Op Cash Flow
-$33.8M
EPS Basic
$-0.48
EPS Diluted
$-0.58
EPS Forward
$-0.27
Gross Margin
39.7%
Op Margin
-9.9%
Net Margin
-13.7%
Balance Sheet
Total Assets
$296.3M
Total Liab.
$325.9M
Total Equity
-$29.7M
Cash
$24.3M
LT Debt
$111.3M
Book Value/Sh
$-0.27
Debt/Equity
-6.88x
Current Ratio
1.35
Quick Ratio
0.76
Returns & Growth
ROE
104.5%
ROA
-23.1%
ROIC
-14.9%
Rev Growth YoY
-3.9%
EPS Growth YoY
+47.2%
Price Returns
2W
-3.8%
1M
-18.9%
3M
-42.3%
6M
-49.2%
12M
-49.6%
Technicals
52W High
$1.25
52W Low
$0.39
50d MA
$0.48
200d MA
$0.71
RSI (14)
47.10
ATR (14)
$0.03
Beta
1.84
Avg Volume
369K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$2.87
High
$6.00
Low
$1.10
Median
$1.50
Data updated apr 26, 2026 8:49pm
· Source: financialmodelingprep.com